In agreement, a recent study also demonstrated that PERK and GCN2 activate MYC, a proto-oncogenic bHLH transcription factor which engages in tumour growth and proliferation, and its activation is responsible for the tumorigenesis of many human cancers (Tameire et al., 2019). Here, EIF2AK4 is linked to cancer.